Prevalence of Migraine in General Spanish Population; Factors Related and Use of Health Resources

Alejandro Salazar, Laura Berrocal, Inmaculada Failde, Alejandro Salazar, Laura Berrocal, Inmaculada Failde

Abstract

Migraine is a common neurological disorder considered the second most disabling condition worldwide. Its prevalence ranges from 2.6% to 21.7% in population studies. This study aimed to know the prevalence of diagnosed and undiagnosed migraine in the general Spanish adult population, their health care use, and factors related. A descriptive cross-sectional study was undertaken with 23,089 individuals >15 years from the 2017 Spanish National Health Survey. Three groups were defined: people diagnosed with migraine (DM), people reporting undiagnosed migraine (UM) and people without migraine. Sociodemographic, clinical and use of health resources data were collected. The scales Duke Social Support Index (DSSI) and General Health Questionnaire (GHQ-12) were used. Prevalence of DM and UM were determined with 95% confidence intervals. To determine the factors associated with DM and UM, a multinomial logistic regression model was used. The prevalence of DM was 8.6% (95%CI: 8.2-9), and UM, 0.9% (95%CI: 0.8-1). People with DM more frequently visited healthcare professionals (47.8%), required more supplementary tests (86.8), had a higher percentage of hospitalization (11.3%), and used emergency services (45.1%). Women had nearly three times the risk of DM and UM. Worse mental health was a risk factor for UM (OR = 1.20) and DM (OR = 1.18). The greater the work stress, the greater the risk of DM (OR = 1.12). An adequate monitoring and management of migraine in people with these characteristics could contribute to improving their quality of life and reducing costs in the system.

Keywords: headache; health services; healthcare services; mental comorbidity; migraine.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ashina M., Katsarava Z., Do T.P., Buse D.C., Pozo-Rosich P., Özge A., Krymchantowski A.V., Lebedeva E.R., Ravishankar K., Yu S., et al. Migraine: Epidemiology and Systems of Care. Lancet. 2021;397:1485–1495. doi: 10.1016/S0140-6736(20)32160-7.
    1. Yeh W.Z., Blizzard L., Taylor B.V. What Is the Actual Prevalence of Migraine? Brain Behav. 2018;8:e00950. doi: 10.1002/brb3.950.
    1. Woldeamanuel Y.W., Cowan R.P. Migraine Affects 1 in 10 People Worldwide Featuring Recent Rise: A Systematic Review and Meta-Analysis of Community-Based Studies Involving 6 Million Participants. J. Neurol. Sci. 2017;372:307–315. doi: 10.1016/j.jns.2016.11.071.
    1. Lipton R., Stewart W., Diamond S., Diamond M., Reed M. Prevalence and Burden of Migraine in the United States: Data from the American Migraine Study II. Headache. 2001;41:646–657. doi: 10.1046/j.1526-4610.2001.041007646.x.
    1. Lipton R., Munjal S., Alam A., Buse D., Fanning K., Reed M., Schwedt T., Dodick D. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache. 2018;58:1408–1426. doi: 10.1111/head.13407.
    1. Peng K., Wang S. Epidemiology of Headache Disorders in the Asia-Pacific Region. Headache. 2014;54:610–618. doi: 10.1111/head.12328.
    1. Navarro-Pérez M.P., Marín-Gracia M., Bellosta-Diago E., Santos-Lasaosa S. Epidemiology of Migraine in Spain and Latin America. Rev. De Neurol. 2020;71:110–118. doi: 10.33588/RN.7103.2019266.
    1. Roy R., Sánchez-Rodríguez E., Galán S., Racine M., Castarlenas E., Jensen M.P., Miró J. Factors Associated with Migraine in the General Population of Spain: Results from the European Health Survey 2014. Pain Med. 2019;20:555–563. doi: 10.1093/pm/pny093.
    1. Fernández-de-las-Peñas C., Palacios-Ceña D., Salom-Moreno J., López-de-Andres A., Hernández-Barrera V., Jiménez-Trujillo I., Jiménez-García R., Gallardo-Pino C., García-Gómez-de-las-Heras M.S., Carrasco-Garrido P. Has the Prevalence of Migraine Changed over the Last Decade (2003–2012)? A Spanish Population-Based Survey. PLoS ONE. 2014;9:e110530. doi: 10.1371/journal.pone.0110530.
    1. Linde M., Stovner L.J., Zwart J.A., Hagen K. Time Trends in the Prevalence of Headache Disorders. the Nord-Trøndelag Health Studies (HUNT 2 and HUNT 3) Cephalalgia. 2011;31:585–596. doi: 10.1177/0333102410391488.
    1. Rafique N., Al-Asoom L.I., Latif R., Alsunni A.A., Salem A.M., Alkhalifa Z.H., Almaharfi R.M., Alramadan R.S., Aldajani Z.F., Alghadeer F.A.T., et al. Prevalence of Migraine and Its Relationship with Psychological Stress and Sleep Quality in Female University Students in Saudi Arabia. J. Pain Res. 2020;13:2423–2430. doi: 10.2147/JPR.S270847.
    1. Lipton R.B., Buse D.C., Adams A.M., Varon S.F., Fanning K.M., Reed M.L. Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale. Headache. 2017;57:570–585. doi: 10.1111/head.13028.
    1. Dresler T., Caratozzolo S., Guldolf K., Huhn J.I., Loiacono C., Niiberg-Pikksööt T., Puma M., Sforza G., Tobia A., Ornello R., et al. Understanding the Nature of Psychiatric Comorbidity in Migraine: A Systematic Review Focused on Interactions and Treatment Implications. J. Headache Pain. 2019;20:1–17. doi: 10.1186/s10194-019-0988-x.
    1. Goulart A.C., Santos I.S., Brunoni A.R., Nunes M.A., Passos V.M., Griep R.H., Lotufo P.A., Benseñor I.M. Migraine Headaches and Mood/Anxiety Disorders in the ELSA Brazil. Headache. 2014;54:1310–1319. doi: 10.1111/head.12397.
    1. Zwart J.A., Dyb G., Hagen K., Ødegård K.J., Dahl A.A., Bovim G., Stovner L.J. Depression and Anxiety Disorders Associated with Headache Frequency. The Nord-Trøndelag Health Study. Eur. J. Neurol. 2003;10:147–152. doi: 10.1046/j.1468-1331.2003.00551.x.
    1. Oedegaard K.J., Neckelmann D., Mykletun A., Dahl A.A., Zwart J.A., Hagen K., Fasmer O.B. Migraine with and without Aura: Association with Depression and Anxiety Disorder in a Population-Based Study. The HUNT Study. Cephalalgia. 2006;26:1–6. doi: 10.1111/j.1468-2982.2005.00974.x.
    1. Minen M.T., de Dhaem O.B., van Diest A.K., Powers S., Schwedt T.J., Lipton R., Silbersweig D. Migraine and Its Psychiatric Comorbidities. J. Neurol. Neurosurg. Psychiatry. 2016;87:741–749. doi: 10.1136/jnnp-2015-312233.
    1. Lafata J.E., Moon C., Leotta C., Kolodner K., Poisson L., Lipton R.B. The Medical Care Utilization and Costs Associated with Migraine Headache. J. Gen. Intern. Med. 2004;19:1005–1012. doi: 10.1111/j.1525-1497.2004.30021.x.
    1. Hjalte F., Olofsson S., Persson U., Linde M. Burden and Costs of Migraine in a Swedish Defined Patient Population—A Questionnaire-Based Study. J. Headache Pain. 2019;20:65. doi: 10.1186/s10194-019-1015-y.
    1. Badia X., Magaz S., Gutiérrez L., Galván J. The Burden of Migraine in Spain: Beyond Direct Costs. Pharmacoeconomics. 2004;22:591–603. doi: 10.2165/00019053-200422090-00004.
    1. Darbà J., Marsà A. Analysis of the Management and Costs of Headache Disorders in Spain during the Period 2011-2016: A Retrospective Multicentre Observational Study. BMJ Open. 2020;10:e034926. doi: 10.1136/bmjopen-2019-034926.
    1. Spanish National Statistics Institute Official Website of the Spanish National Statistics Institute. [(accessed on 7 June 2021)]. Available online:
    1. Bellón J., Delgado A., Luna J., Lardelli P. Validez y Fiabilidad Del Cuestionario de Apoyo Social Funcional Duke-UNC-11. Atención Primaria. 1996;18:153–163.
    1. Gelaye B., Tadesse M.G., Lohsoonthorn V., Lertmeharit S., Pensuksan W.C., Sanchez S.E., Lemma S., Berhane Y., Vélez J.C., Barbosa C., et al. Psychometric Properties and Factor Structure of the General Health Questionnaire as a Screening Tool for Anxiety and Depressive Symptoms in a Multi-National Study of Young Adults. J. Affect. Disord. 2015;187:197–202. doi: 10.1016/j.jad.2015.08.045.
    1. Korolainen M.A., Kurki S., Lassenius M.I., Toppila I., Costa-Scharplatz M., Purmonen T., Nissilä M. Burden of Migraine in Finland: Health Care Resource Use, Sick-Leaves and Comorbidities in Occupational Health Care. J. Headache Pain. 2019;20:13. doi: 10.1186/s10194-019-0964-5.
    1. Fernandez-de-Las-Penas C., Hernandez-Barrera V., Carrasco-Garrido P., Alonso-Blanco C., Palacios-Cena D., Jimenez-Sanchez S., Jimenez-Garcia R. Population-Based Study of Migraine in Spanish Adults: Relation to Socio-Demographic Factors, Lifestyle and Co-Morbidity with Other Conditions. J. Headache Pain. 2010;11:97–104. doi: 10.1007/s10194-009-0176-5.
    1. Todd C., Lagman-Bartolome A.M., Lay C. Women and Migraine: The Role of Hormones. Curr. Neurol. Neurosci. Rep. 2018;18:42. doi: 10.1007/s11910-018-0845-3.
    1. Wang X.-P., Liu J.-M., Zhao Y.-B. Migraine: Sex-Influenced Trait Model? Med. Hypotheses. 2008;71:14–21. doi: 10.1016/j.mehy.2007.12.015.
    1. Ashina M., Terwindt G.M., Al-Karagholi M.A.-M., de Boer I., Lee M.J., Hay D.L., Schulte L.H., Hadjikhani N., Sinclair A.J., Ashina H., et al. Migraine: Disease Characterisation, Biomarkers, and Precision Medicine. Lancet. 2021;397:1496–1504. doi: 10.1016/S0140-6736(20)32162-0.
    1. Bergman-Bock S. Associations Between Migraine and the Most Common Psychiatric Co-Morbidities. Headache. 2018;58:346–353. doi: 10.1111/head.13146.
    1. Zhang Q., Shao A., Jiang Z., Tsai H., Liu W. The Exploration of Mechanisms of Comorbidity between Migraine and Depression. J. Cell. Mol. Med. 2019;23:4505–4513. doi: 10.1111/jcmm.14390.
    1. Karimi L., Wijeratne T., Crewther S.G., Evans A.E., Ebaid D., Khalil H. The Migraine-Anxiety Comorbidity Among Migraineurs: A Systematic Review. Front. Neurol. 2021;11:613372. doi: 10.3389/fneur.2020.613372.
    1. Santos I.S., Griep R.H., Alves M.G.M., Goulart A.C., Lotufo P.A., Barreto S.M., Chor D., Benseñor I.M. Job Stress Is Associated with Migraine in Current Workers: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Eur. J. Pain. 2014;18:1290–1297. doi: 10.1002/j.1532-2149.2014.489.x.
    1. Martelletti P., Schwedt T.J., Lanteri-Minet M., Quintana R., Carboni V., Diener H.C., Ruiz De La Torre E., Craven A., Rasmussen A.V., Evans S., et al. My Migraine Voice Survey: A Global Study of Disease Burden among Individuals with Migraine for Whom Preventive Treatments Have Failed. J. Headache Pain. 2018;19:115. doi: 10.1186/s10194-018-0946-z.
    1. Dueñas M., Ojeda B., Salazar A., Fernández-Palacín F., Mico J., Torres L., Failde I. Use and Satisfaction with the Healthcare System of the Chronic Pain Patients in Spain. Result from a Nationwide Study. Curr. Med Res. Opinion. 2016;32:1813–1820. doi: 10.1080/03007995.2016.1211519.
    1. Salazar A., Dueñas M., Ojeda B., Failde I. Association of Painful Musculoskeletal Conditions and Migraine Headache with Mental and Sleep Disorders among Adults with Disabilities, Spain, 2007-2008. Prev. Chronic Dis. 2014;11:E30. doi: 10.5888/pcd11.130144.
    1. Pérez C., Navarro A., Saldaña M.T., Wilson K., Rejas J. Modeling the Predictive Value of Pain Intensity on Costs and Resources Utilization in Patients with Peripheral Neuropathic Pain. Clin. J. Pain. 2015;31:273–279. doi: 10.1097/AJP.0000000000000110.
    1. Sadosky A.B., DiBonaventura M., Cappelleri J.C., Ebata N., Fujii K. The Association between Lower Back Pain and Health Status, Work Productivity, and Health Care Resource Use in Japan. J. Pain Res. 2015;8:119–130. doi: 10.2147/JPR.S76649.
    1. Blyth F.M., March L.M., Brnabic A.J., Cousins M.J. Chronic Pain and Frequent Use of Health Care. Pain. 2004;111:51–58. doi: 10.1016/j.pain.2004.05.020.
    1. Keeley P., Creed F., Tomenson B., Todd C., Borglin G., Dickens C. Psychosocial Predictors of Health-Related Quality of Life and Health Service Utilisation in People with Chronic Low Back Pain. Pain. 2008;135:142–150. doi: 10.1016/j.pain.2007.05.015.
    1. Lipton R.B., Bigal M.E. Ten Lessons on the Epidemiology of Migraine. Headache. 2007;47:770–771. doi: 10.1111/j.1526-4610.2007.00671.x.
    1. Crow R., Gage H., Hampson S., Hart J., Kimber A., Storey L., Thomas H. The Measurement of Satisfaction with Healthcare: Implications for Practice from a Systematic Review of the Literature. Health Technol. Assess. 2002;6:1–244. doi: 10.3310/hta6320.

Source: PubMed

3
Se inscrever